Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Biotechnology Journal|January 22, 2021
Generation of enzymatically competent SARS-CoV-2 decoy receptor ACE2-Fc in glycoengineered Nicotiana benthamianaAlexandra Castilho, Jennifer Schwestka, Nikolaus F Kienzl, et al.Nature Genetics|August 18, 2014
Jagunal homolog 1 is a critical regulator of neutrophil function in fungal host defenseGerald Wirnsberger, Florian Zwolanek, Johannes Stadlmann, et al.Elife|December 20, 2021
Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptorTümay Capraz, Nikolaus F Kienzl, Elisabeth Laurent, et al.The Journal of Experimental Medicine|September 15, 2020
A crucial role for Jagunal homolog 1 in humoral immunity and antibody glycosylation in mice and humansAstrid Hagelkruys, Gerald Wirnsberger, Johannes Stadlmann, et al.Cell Stem Cell|December 6, 2011
Forward and reverse genetics through derivation of haploid mouse embryonic stem cellsUlrich Elling, Jasmin Taubenschmid, Gerald Wirnsberger, et al.Nature Communications|December 24, 2022
Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule levelRong Zhu, Daniel Canena, Mateusz Sikora, et al.Cell|April 26, 2020
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2Vanessa Monteil, Hyesoo Kwon, Patricia Prado, et al.Biorxiv : the Preprint Server for Biology|September 21, 2021
Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variantsGerald Wirnsberger, Vanessa Monteil, Brett Eaton, et al.Elife|January 13, 2022
ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathologyRiem Gawish, Philipp Starkl, Lisabeth Pimenov, et al.Nature Communications|January 22, 2014
A dual role for autophagy in a murine model of lung cancerShuan Rao, Luigi Tortola, Thomas Perlot, et al.Pageof 4